Clinical Trial: A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Scalp Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Demonstration of the Hair and Scalp Benefits of 0.045% Tazarotene/0.01% Halobetasol Lotion in Scalp Psoriasis
Brief Summary:
The objectives of this research are to demonstrate the following:1.To demonstrate improvement in hair growth and hair appearance following 12 weeks of once daily treatment with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.2.To demonstrate improvement in scalp itch reduction following 12 weeks of once daily treatment with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.3.To pictorially demonstrate improvement in moderate to severe…
Read more